|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3172232 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15738925.5 |
| Date of filing the European patent application | 2015-07-17 | |
| (97) | Date of publication of the European application | 2017-05-31 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-27 |
| (46) | Date of publication of the claims translation | 2024-02-12 |
| (86) | Number | PCT/EP2015/066501 |
| Date | 2015-07-17 |
| (87) | Number | WO 2016/009086 |
| Date | 2016-01-21 |
| (30) | Number | Date | Country code |
| 14177547 | 2014-07-17 | EP | |
| 14194893 | 2014-11-26 | EP |
| (72) |
HENRIKSEN, Anette , DK
KJAERGAARD, Kristian , DK
WESTPHAL STENNICKE, Vibeke , DK
WIBERG, Charlotte , DK
|
| (73) |
Novo Nordisk A/S ,
Novo Allé, 2880 Bagsværd,
DK
|
| (74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Į vietą nukreipta TREM-1 antikūnų mutagenezė, skirta klampumui sumažinti |
| SITE DIRECTED MUTAGENESIS OF TREM-1 ANTIBODIES FOR DECREASING VISCOSITY. |
| Payment date | Validity (years) | Amount | |
| 2025-06-18 | 11 | 289.00 EUR |
| 2026-07-17 |